Trial Profile
An open-label extension of a randomized, double-blind, placebo-controlled, crossover study to evaluate simvastatin 20 mg plus Omacor [omega 3 ethylester concentrate] 4g compared to simvastatin 20 mg plus placebo in subjects with mixed dyslipidemia
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 09 Jun 2008
Price :
$35
*
At a glance
- Drugs Omega-3-acid ethyl esters (Primary) ; Simvastatin
- Indications Dyslipidaemias
- Focus Therapeutic Use
- 09 Jun 2008 New trial record.